Gun Min Kim

2.2k total citations
91 papers, 1.3k citations indexed

About

Gun Min Kim is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Gun Min Kim has authored 91 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Oncology, 40 papers in Pulmonary and Respiratory Medicine and 31 papers in Cancer Research. Recurrent topics in Gun Min Kim's work include Advanced Breast Cancer Therapies (25 papers), Cancer Treatment and Pharmacology (21 papers) and Breast Cancer Treatment Studies (18 papers). Gun Min Kim is often cited by papers focused on Advanced Breast Cancer Therapies (25 papers), Cancer Treatment and Pharmacology (21 papers) and Breast Cancer Treatment Studies (18 papers). Gun Min Kim collaborates with scholars based in South Korea, United States and Japan. Gun Min Kim's co-authors include Joohyuk Sohn, Sun Young Rha, Hyun Cheol Chung, Yong Wha Moon, Seung Ah Lee, Sewha Kim, Hee Jung An, Seung‐Ki Kim, Kamal Pandey and Sun Min Lim and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Gun Min Kim

87 papers receiving 1.3k citations

Peers

Countries citing papers authored by Gun Min Kim

Since Specialization

Citations

This map shows the geographic impact of Gun Min Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gun Min Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gun Min Kim more than expected).

Fields of papers citing papers by Gun Min Kim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gun Min Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gun Min Kim. The network helps show where Gun Min Kim may publish in the future.

Co-authorship network of co-authors of Gun Min Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Gun Min Kim. A scholar is included among the top collaborators of Gun Min Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gun Min Kim. Gun Min Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	GX-I7, a long-acting IL-7, safely and effectively increased peripheral CD8+/CD4+ T cells and TILs in patients with locally advanced or metastatic solid tumours 2025 ·British Journal of Cancer ·Gun Min Kim, So Jeong Kim, Myung Ah Lee, (unknown), Donghoon Choi, Se Hwan Yang, Jungwon Woo, (unknown), (unknown), Su‐Hyung Park, Tae Won Kim, Joohyuk Sohn	2
2	Phase IB and II study of ribociclib with trastuzumab plus endocrine therapy in HR+/HER2+ advanced breast cancer patients: Korean Cancer Study Group BR 18-2 MINI trial. 2025 ·Journal of Clinical Oncology ·Joohyuk Sohn, (unknown), Jae Ho Jeong, Kyung-Hun Lee, Keun Seok Lee, Yong Wha Moon, Ji‐Yeon Kim, Jieun Lee, Hee Jun Kim, Yee Soo Chae, Jee Hung Kim, Suee Lee, In Hae Park, Seok Yun Kang, Kyong Hwa Park, Eun Kyung Cho, Han Jo Kim, Gun Min Kim, Min Hwan Kim, (unknown)	0
3	Combined inhibition of CDK4/6 and AKT is highly effective against the luminal androgen receptor (LAR) subtype of triple negative breast cancer 2024 ·Cancer Letters ·(unknown), Gun Min Kim, (unknown), Fabiana Napolitano, Chang‐Ching Lin, (unknown), (unknown), Yisheng Fang, Kyung‐min Lee, Saurabh Mendiratta, Ariella B. Hanker, Carlos L. Arteaga	3
4	Abstract PO2-27-09: Clinical impact of routine MRI screening for brain metastases in patients with HER2 positive or triple negative metastatic breast cancer 2024 ·Cancer Research ·Gun Min Kim, Joohyuk Sohn, Min Hwan Kim, Seul‐Gi Kim, Hyung Soon Park, (unknown), Yong Bae Kim, (unknown)	3
5	Palbociclib plus exemestane with GnRH agonist vs capecitabine in premenopausal patients with HR+/HER2- metastatic breast cancer: Updated survival results of the randomized phase 2 study Young-PEARL. 2024 ·Journal of Clinical Oncology ·Yeon Hee Park, Kyung-Hun Lee, Gun Min Kim, Seok Yun Kang, Keun Seok Lee, Jee Hyun Kim, Kyoung Eun Lee, Hee Kyung Ahn, Moon Hee Lee, Hee Jun Kim, (unknown), Su‐Jin Koh, Ji‐Yeon Kim, Joohyuk Sohn, Sung‐Bae Kim, Jin Seok Ahn, Seonwoo Kim, Hyun Cho, Kyung Hae Jung, Seock‐Ah Im	1
6	A phase 1 dose expansion study of a first-in-class KAT6 inhibitor (PF-07248144) in patients with advanced or metastatic ER+ HER2− breast cancer. 2024 ·Journal of Clinical Oncology ·Toru Mukohara, (unknown), David Sommerhalder, Kan Yonemori, Sung‐Bae Kim, Jee Hyun Kim, Hiroji Iwata, Toshinari Yamashita, Rachel M. Layman, Gun Min Kim, Seock‐Ah Im, Geoffrey J. Lindeman, Hope S. Rugo, (unknown), (unknown), (unknown), (unknown), Li Liu, (unknown), Patricia LoRusso	2
7	On-treatment derived neutrophil-to-lymphocyte ratio and survival with palbociclib and endocrine treatment: analysis of a multicenter retrospective cohort and the PALOMA-2/3 study with immune correlates 2023 ·Breast Cancer Research ·Chang Gon Kim, Min Hwan Kim, Jee Hung Kim, Seul‐Gi Kim, Gun Min Kim, Tae Yeong Kim, (unknown), Jee Ye Kim, Hyung Seok Park, Seho Park, Young Up Cho, Byeong‐Woo Park, Seung Il Kim, Joon Jeong, Joohyuk Sohn	14
8	Outcomes of an Acute Palliative Care Unit at a Comprehensive Cancer Center in Korea 2023 ·SHILAP Revista de lepidopterología ·(unknown), Jung Hye Kwon, Seung‐Hoon Beom, Sang Joon Shin, Hyo Song Kim, Sun Young Rha, Minkyu Jung, Joohyuk Sohn, Joong Bae Ahn, Hyun Cheol Chung, Gun Min Kim, Hye Ryun Kim, Beodeul Kang, (unknown), Hye Jin Choi	1
9	Anaemia and pathologic complete response rate according to carboplatin dose in HER2+ breast cancer treated with neoadjuvant TCHP 2022 ·Cancer Medicine ·(unknown), Soong June Bae, Seul‐Gi Kim, Min Hwan Kim, Gun Min Kim, Joohyuk Sohn, Joon Jeong, Jee Hung Kim, Sung Gwe Ahn	3
10	Genomic landscape of extraordinary responses in metastatic breast cancer 2021 ·Communications Biology ·Sun Min Lim, Eun‐Young Kim, Kyung Hae Jung, Sora Kim, Ja Seung Koo, Seung Il Kim, Seho Park, Hyung Seok Park, Byeong‐Woo Park, Young Up Cho, Jee Ye Kim, Soonmyung Paik, Nak‐Jung Kwon, Gun Min Kim, (unknown), Min Hwan Kim, (unknown), Sangwoo Kim, Joohyuk Sohn	4
11	Patient-Reported Outcomes of Palbociclib Plus Exemestane with GnRH Agonist versus Capecitabine in Premenopausal Women with Hormone Receptor-Positive Metastatic Breast Cancer: A Prospective, Open-Label, Randomized Phase ll Trial (KCSG-BR 15-10) 2020 ·Cancers ·Soo Hyun Lee, Seock‐Ah Im, Gun Min Kim, Kyung Hae Jung, Seok Yun Kang, In Hae Park, Jee Hyun Kim, Kyoung Eun Lee, Hee Kyung Ahn, Moon Hee Lee, Hee Jun Kim, Han Jo Kim, Jong In Lee, Su‐Jin Koh, Yeon Hee Park	13
12	Intermediate HER2 expression is associated with poor prognosis in estrogen receptor-positive breast cancer patients aged 55 years and older 2019 ·Breast Cancer Research and Treatment ·Min Hwan Kim, Gun Min Kim, Jee Hung Kim, Jee Ye Kim, Hyung Seok Park, Seho Park, Young Up Cho, Byeong‐Woo Park, Seung Il Kim, Joohyuk Sohn	13
13	Quality of life outcomes including neuropathy‐associated scale from a phase II, multicenter, randomized trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine as first‐line chemotherapy for HER2‐negative metastatic breast cancer: Korean Cancer Study Group Trial (KCSG BR13‐11) 2019 ·Cancer Communications ·Ji‐Yeon Kim, Seri Park, Seock‐Ah Im, Sung‐Bae Kim, Joohyuk Sohn, Keun Seok Lee, Yee Soo Chae, Ki Hyeong Lee, Jee Hyun Kim, Young‐Hyuck Im, Tae‐Yong Kim, Kyung‐Hun Lee, Jin‐Hee Ahn, Gun Min Kim, In Hae Park, Soo Jung Lee, Hye Sook Han, Se Hyun Kim, Kyung Hae Jung, Yeon Hee Park, (unknown)	3
14	External validation of IBTR! 2.0 nomogram for prediction of ipsilateral breast tumor recurrence 2018 ·Radiation Oncology Journal ·Byung Min Lee, Jee Suk Chang, Young Up Cho, Seho Park, Hyung Seok Park, Jee Ye Kim, Joohyuk Sohn, Gun Min Kim, Ja Seung Koo, Ki Chang Keum, Chang‐Ok Suh, Yong Bae Kim	7
15	Comparative clinicopathological and cytomorphological analyses of peritoneal carcinomatosis associated with metastatic breast carcinoma and primary peritoneal/ovarian carcinoma in patients with a history of breast carcinoma 2018 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·Kiyong Na, Jung‐Yun Lee, Ji‐Youn Sung, Gun Min Kim, Ja Seung Koo, Hyun Soo Kim	16
16	Prevalence and prognostic implications of psychological distress in patients with gastric cancer 2017 ·BMC Cancer ·Gun Min Kim, Seung Jun Kim, Su Kyung Song, Hye Ryun Kim, (unknown), Sung Hoon Noh, Hyun Cheol Chung, Kyung Ran Kim, Sun Young Rha	96
17	Feasibility of Charcoal Tattooing of Cytology-Proven Metastatic Axillary Lymph Node at Diagnosis and Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Breast Cancer Patients 2017 ·Cancer Research and Treatment ·Seho Park, Ja Seung Koo, Gun Min Kim, Joohyuk Sohn, Seung Il Kim, Young Up Cho, Byeong‐Woo Park, Vivian Youngjean Park, Jung Hyun Yoon, Hee Jung Moon, Min Jung Kim, Eun‐Kyung Kim	57
18	18F-FDG PET/CT in hepatocellular carcinoma 2014 ·Nuclear Medicine Communications ·Hyo Jung Seo, Gun Min Kim, Joo Hoon Kim, Won Jun Kang, Hye Jin Choi	17
19	The first step on earth: A small step for a trial, a giant leap for mankind 2012 ·Gun Min Kim, Hyun Cheol Chung	1
20	Gastrointestinal Complication in Transplant Patients 2010 ·Clinical Endoscopy ·Gun Min Kim, Dae Young Cheung, Jin Il Kim	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact